Neurogene Inc (NGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Operating Expenses | 12,596 | 13,035 | 11,672 | 13,609 | 15,871 |
| Operating Income | -12,596 | -13,035 | -11,672 | -13,609 | -15,871 |
| Interest Expense | 3 | 2 | 0 | 0 | 0 |
| Other Income | 739 | 774 | 594 | 537 | 183 |
| Pre-tax Income | -11,860 | -12,263 | -11,078 | -13,072 | -15,688 |
| Net Income Continuous | -11,860 | -12,263 | -11,078 | -13,072 | -15,688 |
| Net Income | $-11,860 | $-12,263 | $-11,078 | $-13,072 | $-15,688 |
| EPS Basic Total Ops | -26.68 | -28.28 | -123.80 | -4.72 | -5.60 |
| EPS Basic Continuous Ops | -26.71 | -28.26 | -123.74 | -4.73 | -5.68 |
| EPS Diluted Total Ops | -26.68 | -28.28 | -123.80 | -4.72 | -5.60 |
| EPS Diluted Continuous Ops | -26.71 | -28.26 | -123.74 | -4.73 | -5.68 |
| EBITDA(a) | $-11,773 | $-12,217 | $-10,336 | $-13,127 | $-15,150 |